This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astra Zeneca U.k. Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Azadeh Cheraghchi Bashi Astaneh: A Patent in Cancer Therapy
Introduction
Azadeh Cheraghchi Bashi Astaneh is an inventor associated with Cambridge, Great Britain. Her patent work includes research into targeted cancer treatments.
Latest Patents
Her listed patent is “Combination of Anti-HER2 Antibody-Drug Conjugate and PARP1 Selective Inhibitor.” The invention concerns combining an anti-HER2 antibody-drug conjugate with a selective PARP1 inhibitor. She is credited with 1 patent.
Career Highlights
Astaneh has been associated with AstraZeneca UK Limited and Daiichi Sankyo Company, Limited. Her patent reflects work in pharmaceutical research and cancer therapy.
Collaborations
Her listed coworkers include Yann Wallez and Jerome Thomas Mettetal.
Conclusion
Azadeh Cheraghchi Bashi Astaneh’s patent activity highlights her contribution to research on combination approaches for targeted cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile